|
1
|
Hussain SA and James ND: The systemic
treatment of advanced and metastatic bladder cancer. Lancet Oncol.
4:489–497. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Overdevest JB, Thomas S, Kristiansen G,
Hansel DE, Smith SC and Theodorescu D: CD24 offers a therapeutic
target for control of bladder cancer metastasis based on a
requirement for lung colonization. Cancer Res. 71:3802–3811. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Huang Z, Zhu Z, Zheng X, Liu J,
Han Z, Ma X and Zhang Y: Upregulated UHRF1 promotes bladder cancer
cell invasion by epigenetic silencing of KiSS1. PLoS One.
9:e1042522014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kusenda B, Mraz M, Mayer J and Pospisilova
S: MicroRNA biogenesis, functionality and cancer relevance. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub. 150:205–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zabolotneva AA, Zhavoronkov A, Garazha AV,
Roumiantsev SA and Buzdin AA: Characteristic patterns of microRNA
expression in human bladder cancer. Front Genet. 3:3102013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Papagiannakopoulos T, Friedmann-Morvinski
D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch
DH, Barres BA, et al: Pro-neural miR-128 is a glioma tumor
suppressor that targets mitogenic kinases. Oncogene. 31:1884–1895.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan
X, Gong Y, Yin B, Liu W, Qiang B, et al: MicroRNA-128 inhibits
glioma cells proliferation by targeting transcription factor E2F3a.
J Mol Med (Berl). 87:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi ZM, Wang J, Yan Z, You YP, Li CY, Qian
X, Yin Y, Zhao P, Wang YY, Wang XF, et al: MiR-128 inhibits tumor
growth and angiogenesis by targeting p70S6K1. PLoS One.
7:e327092012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin L, Chen X, Peng X, Zhou J, Kung HF,
Lin MC and Jiang S: MicroRNA-128 promotes cell-cell adhesion in U87
glioma cells via regulation of EphB2. Oncol Rep. 30:1239–1248.
2013.PubMed/NCBI
|
|
12
|
Dong Q, Cai N, Tao T, Zhang R, Yan W, Li
R, Zhang J, Luo H, Shi Y, Luan W, et al: An axis involving SNAI1,
microRNA-128 and SP1 modulates glioma progression. PLoS One.
9:e986512014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peruzzi P, Bronisz A, Nowicki MO, Wang Y,
Ogawa D, Price R, Nakano I, Kwon CH, Hayes J, Lawler SE, et al:
MicroRNA-128 coordinately targets polycomb repressor complexes in
glioma stem cells. Neuro Oncol. 15:1212–1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi Y, Iwaya T, Sawada G, Kurashige
J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, et al:
Up-regulation of NEK2 by microRNA-128 methylation is associated
with poor prognosis in colorectal cancer. Ann Surg Oncol.
21:205–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Evangelisti C, Florian MC, Massimi I,
Dominici C, Giannini G, Galardi S, Buè MC, Massalini S, McDowell
HP, Messi E, et al: MiR-128 up-regulation inhibits Reelin and DCX
expression and reduces neuroblastoma cell motility and
invasiveness. FASEB J. 23:4276–4287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khan AP, Poisson LM, Bhat VB, Fermin D,
Zhao R, Kalyana-Sundaram S, Michailidis G, Nesvizhskii AI, Omenn
GS, Chinnaiyan AM and Sreekumar A: Quantitative proteomic profiling
of prostate cancer reveals a role for miR-128 in prostate cancer.
Mol Cell Proteomics. 9:298–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adlakha YK and Saini N: MicroRNA-128
downregulates Bax and induces apoptosis in human embryonic kidney
cells. Cell Mol Life Sci. 68:1415–1428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guidi M, Muiños-Gimeno M, Kagerbauer B,
Martí E, Estivill X and Espinosa-Parrilla Y: Overexpression of
miR-128 specifically inhibits the truncated isoform of NTRK3 and
upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol Biol.
11:952010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li B, Chen H, Wu N, Zhang WJ and Shang LX:
Deregulation of miR-128 in ovarian cancer promotes cisplatin
resistance. Int J Gynecol Cancer. 24:1381–1388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
She X, Yu Z, Cui Y, Lei Q, Wang Z, Xu G,
Xiang J, Wu M and Li G: MiR-128 and miR-149 enhance the
chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal
remodeling in glioblastoma. Oncol Rep. 32:957–964. 2014.PubMed/NCBI
|
|
21
|
Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao
H, Gong C, Chen J, Su F, Zhang Y and Song E: Reduced miR-128 in
breast tumor-initiating cells induces chemotherapeutic resistance
via Bmi-1 and ABCC5. Clin Cancer Res. 17:7105–7115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian Z, Guo B, Yu M, Wang C, Zhang H,
Liang Q, Jiang K and Cao L: Upregulation of micro-ribonucleic
acid-128 cooperating with downregulation of PTEN confers metastatic
potential and unfavorable prognosis in patients with primary
osteosarcoma. Onco Targets Ther. 7:1601–1608. 2014.PubMed/NCBI
|
|
23
|
Mylona E, Magkou C, Gorantonakis G,
Giannopoulou I, Nomikos A, Zarogiannos A, Zervas A and Nakopoulou
L: Evaluation of the vascular endothelial growth factor (VEGF)-C
role in urothelial carcinomas of the bladder. Anticancer Res.
26:3567–3571. 2006.PubMed/NCBI
|
|
24
|
Li Z, Qi F, Qi L, Zhang H, Chen M, Wang L
and Zu X: VEGF-C as a decision-making biomarker for selected
patients with invasive bladder cancer who underwent
bladder-preserving radical surgery. Arch Med Res. 42:405–411. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzuki K, Morita T and Tokue A: Vascular
endothelial growth factor-C (VEGF-C) expression predicts lymph node
metastasis of transitional cell carcinoma of the bladder. Int J
Urol. 12:152–158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zu X, Tang Z, Li Y, Gao N, Ding J and Qi
L: Vascular endothelial growth factor-C expression in bladder
transitional cell cancer and its relationship to lymph node
metastasis. BJU Int. 98:1090–1093. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HH, Qi F, Shi YR, Miao JG, Zhou M,
He W, Chen MF, Li Y, Zu XB and Qi L: RNA interference-mediated
vascular endothelial growth factor-C reduction suppresses malignant
progression and enhances mitomycin C sensitivity of bladder cancer
T24 cells. Cancer Biother Radiopharm. 27:291–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G,
Fu S, Zhang Y, Feng K and Feng Y: microRNA-128 plays a critical
role in human non-small cell lung cancer tumourigenesis,
angiogenesis and lymphangiogenesis by directly targeting vascular
endothelial growth factor-C. Eur J Cancer. 50:2336–2350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arocho A, Chen B, Ladanyi M and Pan Q:
Validation of the 2-DeltaDeltaCt calculation as an alternate method
of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barbosa H, Slater NK and Marcos JC:
Protein quantification in the presence of poly(ethylene glycol) and
dextran using the Bradford method. Anal Biochem. 395:108–110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen L, Chen XD and Zhang YH: MicroRNA-128
promotes proliferation in osteosarcoma cells by downregulating
PTEN. Tumour Biol. 35:2069–2074. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tao T, Li G, Dong Q, Liu D, Liu C, Han D,
Huang Y, Chen S, Xu B and Chen M: Loss of SNAIL inhibits cellular
growth and metabolism through the miR-128-mediated
RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells.
Tumour Biol. 35:8543–8550. 2014. View Article : Google Scholar : PubMed/NCBI
|
